ACM Global Laboratories Stands Strong Against COVID-19

As the novel coronavirus (COVID-19) continues to spread in the U.S. and across the globe, know that ACM’s number one priority is the safety and well-being of our people, clients, families, and the communities in which we live and work. Despite the current challenges, ACM Global Laboratories prevails through intelligent and coordinated action, guided by our shared will to promote the health of the patients we serve.

Our local and global communities depend on us to deliver actionable clinical insights that lead to therapies and treatments that provide health, healing and hope to patients around the world. To deliver on our mission throughout these trying times, we will continue to keep our locations open and will operate with normal business hours.

Last week, we officially activated our Global COVID-19 Task Force (GCTF) command structure to operationalize guidance from the Centers for Disease Control and Prevention (CDC) and to provide real-time guidance and communication to our employees, patients, and customers.

To keep all of our employee’s safe, we have implemented and are following the latest prevention guidance from the CDC.

• We are working to ensure the continued availability of personal protective equipment (PPE) for our employees.
• Visitor screening and travel restrictions have been implemented at all ACM facilities.
• We continue to urge social distancing and remote working where appropriate.
• The frequency of cleaning has been stepped up at each of our sites to ensure that our employees have a safe working environment.

We are doing everything we can to keep our teams, our patients, and our community safe. For over 40 years, we have served patients, customers, and communities across the globe and have seen and met many challenges in the past and we will now, once again. We are a strong and powerful force for good and healing in our communities. Thank you for allowing us to continue to serve you through this challenging period.

Brian H. Wright

President, ACM Global Laboratories